Tirzepatide-Based Therapy for Multidomain Metabolic Improvement in an Active Duty Service Member: A Case Report.

Authors

Shawn K Kim

Published in

Cureus. Volume 18. Issue 8. Pages e114114. Epub Aug 07, 2026.

Abstract

Tirzepatide has demonstrated efficacy in multiple domains of metabolic health, such as weight loss, glycemic control, and improvement of metabolic dysfunction-associated steatotic liver disease (MASLD). Despite this, tirzepatide remains understudied and underutilized in the military population. We report a case of a 29-year-old active-duty male with newly diagnosed type 2 diabetes mellitus (T2DM), class II obesity (BMI 35.6 kg/m²), dyslipidemia, and MASLD who experienced marked improvement across multiple metabolic domains over approximately 12 months of tirzepatide-based treatment. This case highlights that a comprehensive treatment approach, including tirzepatide, lifestyle modifications, and adjunctive pharmacotherapy, was associated with substantial multidomain metabolic improvement in young active duty service members (ADSM). Further studies are needed to determine whether these findings translate into broader benefits for military readiness, retention, and healthcare utilization within the Military Health System (MHS).

PMID:
42703498
Bibliographic data and abstract were imported from PubMed on 07 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.